Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients.
Santos
A R
AR
Almeida
A S
AS
Suffys
P N
PN
Moraes
M O
MO
Filho
V F
VF
Mattos
H J
HJ
Nery
J A
JA
Cabello
P H
PH
Sampaio
E P
EP
Sarno
E N
EN
D000483:Alleles; D001938:Brazil; D004269:DNA, Bacterial / Q000737:chemistry / Q000302:isolation & purification; D015252:Deoxyribonucleases, Type II Site-Specific / Q000737:chemistry; D006801:Humans; D015441:Leprosy, Tuberculoid / Q000235:genetics / Q000276:immunology*; D009166:Mycobacterium leprae / Q000235:genetics / Q000276:immunology*; D010865:Pilot Projects; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000235:genetics / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology*
D004269:DNA, Bacterial; D014409:Tumor Necrosis Factor-alpha; C052380:endodeoxyribonuclease NcoI; D015252:Deoxyribonucleases, Type II Site-Specific